Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 35,595 | 31,085 | 34,689 | 43,166 | 41,005 |
| Cost of Goods | 10,469 | 9,132 | 13,956 | 11,047 | 11,052 |
| Gross Profit | 25,126 | 21,953 | 20,733 | 32,118 | 29,952 |
| Operating Expenses | 42,381 | 54,034 | 53,211 | 54,910 | 40,375 |
| Operating Income | -16,786 | -31,949 | -31,522 | -22,745 | -10,370 |
| Other Income | -5,624 | 1,888 | -2,383 | -2,550 | 1,406 |
| Pre-tax Income | -22,410 | -30,061 | -33,905 | -25,295 | -8,964 |
| Income Tax | -1,691 | -814 | -1,093 | -736 | -1,127 |
| Net Income Continuous | -20,719 | -29,247 | -32,813 | -24,559 | -7,837 |
| Net Income | $-20,719 | $-29,247 | $-32,813 | $-24,559 | $-7,837 |
| EPS Basic Total Ops | -0.38 | -0.65 | -0.75 | -0.57 | -0.20 |
| EPS Basic Continuous Ops | -0.38 | -0.65 | -0.75 | -0.57 | -0.20 |
| EPS Diluted Total Ops | -0.38 | -0.65 | -0.75 | -0.57 | -0.20 |
| EPS Diluted Continuous Ops | -0.38 | -0.65 | -0.75 | -0.57 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -0.23 | -0.64 | -0.75 | -0.57 | -0.20 |
| EBITDA(a) | $-14,661 | $-29,925 | $-30,390 | $-21,615 | $-9,387 |